We are live on
!
Find out more
WP
Woodline Partners Portfolio holdings
AUM
$26.4B
1-Year Est. Return
44.85%
This Fund
S&P 500
This Quarter
Est. Return
+4.58%
1 Year Est. Return
+44.85%
3 Year Est. Return
+131.23%
5 Year Est. Return
+174.12%
10 Year Est. Return
–
AUM
$5.36B
AUM Growth
+$854M
(+19%)
Cap. Flow
+$792M
Cap. Flow
% of AUM
14.77%
Top 10 Holdings %
Top 10 Hldgs %
19.89%
Holding
754
New
327
Increased
121
Reduced
79
Closed
168
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
KLA
KLAC
|
+$82.6M |
| 2 |
SGEN
Seagen Inc. Common Stock
SGEN
|
+$78.3M |
| 3 |
HZNP
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
|
+$57.7M |
| 4 |
Teradyne
TER
|
+$56.1M |
| 5 |
AbbVie
ABBV
|
+$52.9M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Danaher
DHR
|
+$66.1M |
| 2 |
Zimmer Biomet
ZBH
|
+$56.1M |
| 3 |
NVIDIA
NVDA
|
+$55.8M |
| 4 |
Regeneron Pharmaceuticals
REGN
|
+$54.7M |
| 5 |
eBay
EBAY
|
+$40.9M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 46.89% |
| 2 | Technology | 25.02% |
| 3 | Communication Services | 8.75% |
| 4 | Financials | 5.58% |
| 5 | Industrials | 4.16% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
CMPS
151
Compass Pathways
CMPS
$1.53B
| $8.41M | 0.16% |
220,359
+29,922
| +16% | +$1.07M |
|
152
Janux Therapeutics
JANX
$925M
| $8.34M | 0.16% |
+334,260
| New | +$7.44M |
|
|
SNRHU
153
DELISTED
Senior Connect Acquisition Corp. I Unit
SNRHU
| $8.31M | 0.15% |
820,780
-1,800
| -0.2% | -$18.2K |
|
154
Century Therapeutics
IPSC
$364M
| $8.27M | 0.15% |
+281,726
| New | +$7.15M |
|
|
HOOK
155
DELISTED
HOOKIPA Pharma
HOOK
| $8.26M | 0.15% |
90,160
+22,134
| +33% | +$2.95M |
|
156
Shoals Technologies Group
SHLS
$1.47B
| $8.26M | 0.15% |
232,542
| – | – |
|
157
Cencora
COR
$60.6B
| $8.2M | 0.15% |
71,581
+4,535
| +7% | +$536K |
|
158
PMV Pharmaceuticals
PMVP
$59.2M
| $8.17M | 0.15% |
239,081
+15,391
| +7% | +$514K |
|
159
Lyell Immunopharma
LYEL
$317M
| $8.11M | 0.15% |
+24,978
| New | +$8.19M |
|
160
Sana Biotechnology
SANA
$871M
| $8.08M | 0.15% |
410,848
+8,854
| +2% | +$201K |
|
|
SEEL
161
DELISTED
Seelos Therapeutics, Inc. Common Stock
SEEL
| $8.04M | 0.15% |
793
+608
| +329% | +$9.99M |
|
|
TPGS
162
DELISTED
TPG Pace Solutions Corp.
TPGS
| $7.97M | 0.15% |
+800,000
| New | +$8.05M |
|
163
News Corp Class A
NWSA
$14.9B
| $7.95M | 0.15% |
308,330
+9,853
| +3% | +$260K |
|
164
Lightspeed Commerce
LSPD
$1.31B
| $7.87M | 0.15% |
+94,168
| New | +$6.62M |
|
|
SWTX
165
DELISTED
SpringWorks Therapeutics
SWTX
| $7.87M | 0.15% |
95,458
-79,870
| -46% | -$6.06M |
|
166
Coty
COTY
$2.42B
| $7.86M | 0.15% |
841,888
+645,940
| +330% | +$5.87M |
|
167
Interparfums
IPAR
$3.99B
| $7.78M | 0.15% |
108,000
+37,807
| +54% | +$2.79M |
|
168
Cue Biopharma
CUE
$113M
| $7.77M | 0.15% |
22,241
+15,481
| +229% | +$6M |
|
|
MAACU
169
DELISTED
Montes Archimedes Acquisition Corp. Unit
MAACU
| $7.71M | 0.14% |
722,880
-4,914
| -0.7% | -$51.5K |
|
170
Palladyne AI
PDYN
$247M
| $7.68M | 0.14% |
+128,253
| New | +$7.64M |
|
171
Freshpet
FRPT
$2.93B
| $7.63M | 0.14% |
46,851
+14,174
| +43% | +$2.42M |
|
172
Lifestance Health
LFST
$4B
| $7.61M | 0.14% |
+273,207
| New | +$7.22M |
|
|
RACB
173
DELISTED
Research Alliance Corp. II Class A Common Stock
RACB
| $7.61M | 0.14% |
750,000
| – | – |
|
174
Edgewise Therapeutics
EWTX
$4.13B
| $7.56M | 0.14% |
354,489
-2,940
| -0.8% | -$80.4K |
|
|
WBA
175
DELISTED
Walgreens Boots Alliance
WBA
| $7.52M | 0.14% |
143,021
+73,335
| +105% | +$3.94M |
|
Similar funds
PAM
TCIIS
UIM
Woodline Partners's Q2 2021 Portfolio in Review
As of Q2 2021, Woodline Partners held 754 positions worth $5.36B, up 19% from $4.51B the previous quarter. Its ten largest holdings account for 20% of the portfolio.
Woodline Partners deployed $792M of net new capital in Q2 2021, opening 327 new positions and adding to 121 existing holdings. Its largest new stake was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
By sector, the portfolio is most concentrated in Healthcare at 47% of assets, down from 48% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was Danaher, an estimated $66.1M trimmed.
- Woodline Partners's largest Q2 2021 buy was Alphabet (Google) Class A: 424,740 shares worth $51.9M.
- Woodline Partners added most to KLA in Q2 2021, an estimated $82.6M increase.
- Woodline Partners's biggest Q2 2021 reduction was Danaher, cutting an estimated $66.1M.
- Woodline Partners fully exited Zimmer Biomet in Q2 2021, selling an estimated $56.1M.
- Woodline Partners's ten largest holdings make up 20% of its $5.36B portfolio in Q2 2021.
- Woodline Partners opened 327 new positions and closed 168 in Q2 2021.
- Woodline Partners's portfolio value rose 19% quarter-over-quarter to $5.36B.
Based on Woodline Partners's 13F filing for Q2 2021, filed 16 Aug 2021.